Terms: = Head and neck cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808 AND Prognosis
5 results:
1. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving head and neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract] [Full Text] [Related]
2. Identify metabolism-related genes IDO1, ALDH2, ncoa2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma.
Li C; Chen S; Jia W; Li W; Wei D; Cao S; Qian Y; Guan R; Liu H; Lei D
Front Immunol; 2022; 13():955614. PubMed ID: 36090994
[TBL] [Abstract] [Full Text] [Related]
3. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
[TBL] [Abstract] [Full Text] [Related]
4. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
[TBL] [Abstract] [Full Text] [Related]
5. head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
[TBL] [Abstract] [Full Text] [Related]